Life Sciences Roundtable Series: Structuring Milestones and Contingent Payments in Biotech, Pharma, and Medtech M&A and Collaborations: U.S. and European Trends
Hosted by McDermott Will & Emery
Location, or Event type: McDermott Will & Emery 23 rue de l’Université 75007 Paris
Life Sciences Roundtable Series: Structuring Milestones and Contingent Payments in Biotech, Pharma, and Medtech M&A and Collaborations: U.S. and European Trends
Virtual Conference, Hosted By McDermott Will & Emery
Tuesday, June 23, 2015 - 10:00 AM
McDermott Will & Emery, JSB-Partners and SRS Acquiom cordially invite you to a complimentary Life Sciences Roundtable and evening reception. JSB-Partners will present recent data from their experience managing over 100 life sciences M&A deals, and our interactive panel will address the key issues and recent trends involved in structuring milestone and contingent payments in collaboration and M&A agreements in both the United States and Europe.
Our panelists will address the following critical issues related to pharmaceutical and medtech deal-making:
Key factors to consider when structuring and drafting clinical, regulatory and sales-based milestone payments
Drafting “due diligence” obligations, and the definition of “commercially reasonable efforts”
Recent developments in life sciences litigation involving milestone payments, earn-outs, contingent consideration and royalty payments
SPEAKERS
Michel Gouy, Partner, JSB-Partners
Amanda Jackson, Director, Business Development, SRS Acquiom
Anthony Paronneau, Partner, McDermott Will & Emery LLP
Emmanuelle Trombe, Partner, McDermott Will & Emery LLP
Kristian A. Werling, Partner, McDermott Will & Emery LLP